Get started
Author

Min Ji Koh

Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
2024 · Jessy Xinyi Han, Min Jung Koh, et al. · Blood Advances · 14
PDF
Role of laminin 332 in lymph node metastasis of papillary thyroid carcinoma
2017 · Kyoung Ho Oh, June Choi, et al. · Auris Nasus Larynx · 11
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes
2024 · Bimarzhan Assatova, Robert Willim, et al. · Clinical Cancer Research · 9
PDF
Forecasting optimal treatments in relapsed/refractory mature T‐ and NK ‐cell lymphomas: A global PETAL Consortium study
2025 · Mark N. Sorial, Jessy Xinyi Han, et al. · British Journal of Haematology · 4
PDF
The impact of neoadjuvant relugolix on multi-dimensional patient-reported fatigue
2024 · Jessica Y. Hsueh, Lindsey Gallagher, et al. · Frontiers in Oncology · 4
PDF
Impact of neoadjuvant relugolix on patient-reported sexual function and bother
2024 · Jessica Y. Hsueh, Lindsey Gallagher, et al. · Frontiers in Oncology · 4
PDF
Late radiation-related lymphopenia after prostate stereotactic body radiation therapy plus or minus supplemental pelvic irradiation
2024 · Kelly Gaudian, Min Jung Koh, et al. · Frontiers in Oncology · 2
PDF
Safety and early efficacy of involved-field SBRT for nodal oligo-recurrent prostate cancer
2024 · Min Ji Koh, Padraig Pilkington, et al. · Frontiers in Oncology · 2
PDF
Utilization of patient-reported outcomes to assess adherence to relugolix when combined with radiation therapy.
2024 · Kelly Gaudian, Min Ji Koh, et al. · Journal of Clinical Oncology · 2
Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer
2025 · Kelly Gaudian, Min Jung Koh, et al. · Frontiers in Oncology · 1
PDF
Novel Causal Inference Method Estimates Treatment Effects of Contemporary Drugs in a Global Cohort of Patients with Relapsed and Refractory Mature T-Cell and NK-Cell Neoplasms
2023 · Min Jung Koh, Leora Boussi, et al. · Blood · 1
PDF
Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary Era
2022 · Leora S Boussi, Min Jung Koh, et al. · Blood · 1
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas
2022 · Min Jung Koh, Mwanasha H. Merrill, et al. · Blood Advances · 1
PDF
Case Series of Intraoperative Indocyanine Green Angiography Findings in Minimally Invasive Surgical Ligation of Cerebrospinal Fluid-Venous Fistulas
2026 · Jason K. Lim, Alan Balu, et al. · Neurosurgery Open
Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium
2026 · Colin J. Thomas, Min Jung Koh, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Persistent bothersome urinary frequency following stereotactic body radiation therapy for clinically localized prostate cancer: rationale for prophylactic β3-agonist in men with elevated baseline international prostate symptom scores
2026 · Jennifer Zack, Min Ji Koh, et al. · Frontiers in Oncology
PDF
Early time-to-relapse as a predictor of survival in mature T-cell/NK-cell lymphomas: Results from the PETAL consortium
2025 · Mark Sorial, Kenechukwu Aniagboso, et al. · Blood
Chronic Prostate Cancer-Related Symptoms and Toxicities Following Stereotactic Body Radiation Therapy: Implications for Future Radionuclide Therapy
2025 · Diya Kallam, Kelly Gaudian, et al. · Cureus
PDF
Fractionated robotic radiosurgery for unfavorable nonfunctioning pituitary macroadenoma: 5-year outcomes from a single institution protocol
2025 · Akrita Bhatnagar, Monica Pernia Marin, et al. · Frontiers in Oncology
Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy
2025 · Min Jung Koh, Min Ji Koh, et al. · Frontiers in Oncology
PDF
Development of a Novel Prognostic Score for Relapsed/Refractory Mature T-Cell and NK-Cell Lymphomas (PIRT): Results from a Global Peripheral T-Cell Lymphoma (PETAL) Consortium
2024 · Min Jung Koh, Jessy Xinyi Han, et al. · Blood
Patient-Reported Xerostomia in Men Treated with Prostate Stereotactic Body Radiation Therapy: Implications for Future Radionuclide Therapy
2024 · D. Kallam, K. Gaudian, et al. · International Journal of Radiation Oncology*Biology*Physics
The Impact of Neoadjuvant Relugolix on Multi-Dimensional Patient-Reported Fatigue
2024 · M.J. Koh, J. Hsueh, et al. · International Journal of Radiation Oncology*Biology*Physics
Supplementary Data 1 from KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes
2024 · Bimarzhan Assatova, Robert Willim, et al.
Supplementary Data 1 from KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes
2024 · Bimarzhan Assatova, Robert Willim, et al.
Works count: 33
Citation count: 55
H-index: 4
I10-index: 2
Year
Topic
Type